PHARMACOKINETICS OF METRONIDAZOLE IN PATIENTS WITH ENTERIC DISEASE COMPARED TO NORMAL VOLUNTEERS

被引：38

作者：

BERGAN, T ^{[1
]}

BJERKE, EM ^{[1
]}

FAUSA, O ^{[1
]}

机构：

[1] RIKSHOSP OSLO,NATL HOSP NORWAY,DEPT MED A,OSLO,NORWAY

来源：

关键词：

D O I：

10.1159/000237985

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：233 / 238

页数：6

共 18 条

[1] ALLAN R, 1977, GUT, V18, pA422
[2] PHARMACOKINETICS OF METRONIDAZOLE IN HEALTHY ADULT VOLUNTEERS AFTER TABLETS AND SUPPOSITORIES
BERGAN, T
ARNOLD, E
[J]. CHEMOTHERAPY, 1980, 26 (04) : 231 - 241
[3] METRONIDAZOLE IN CROHNS-DISEASE - DOUBLE-BLIND CROSSOVER CLINICAL-TRIAL
BLICHFELDT, P
BLOMHOFF, JP
MYHRE, E
GJONE, E
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1978, 13 (01) : 123 - 127
[4] BURROWS FGO, 1974, CLIN GASTROENTEROL, V3, P91
[5] CREAMER B, 1974, COELIAC DISEASE, P348
[6] METRONIDAZOLE IN TREATMENT OF CHRONIC PROCTITIS - CONTROLLED TRIAL
DAVIES, PS
RHODES, J
HEATLEY, RV
OWEN, E
[J]. GUT, 1977, 18 (08) : 680 - 681
[7] DAVIS AE, 1968, AUSTRALAS ANN MED, V17, P63
[8] KANE PO, 1961, BRIT J VENER DIS, V37, P273
[9] MANTILLA MJ, 1973, ARZNEIMITTEL FORSCH, V23, P583
[10] BIOAVAILABILITY OF METRONIDAZOLE IN FASTING AND NON-FASTING HEALTHY SUBJECTS AND IN PATIENTS WITH CROHNS-DISEASE
MELANDER, A
KAHLMETER, G
KAMME, C
URSING, B
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) : 69 - 72